Portfolio
SVLSF I closed in 1994 with total commitments of $100 million.
As at 31 December 2012, SVLSF I had invested $123 million in 31 portfolio companies.
31 matching investments found
| Company | Country | Stage | Sector | Year |
|---|---|---|---|---|
 Allos Therapeutics | US | Early Stage | Biotechnology Biopharmaceuticals | 1998 |
| Allos Therapeutics was developing and commercializing innovative small molecule therapeutics for the treatment of cancer. | ||||
 Axys Pharmaceuticals | US | Early Stage | Biotechnology Biopharmaceuticals | 1994 |
| Axys developed a protease-inhibitor based products for cancer & inflammatory diseases. | ||||
 Cerebrus | UK | Start Up | Biotechnology Biopharmaceuticals | 1995 |
| Cerebrus CNS drug discovery (Acquired by Nigra, which was then bought by Vernalis) | ||||
 Coral Therapeutics | US | Start Up | Healthcare Services | 1994 |
| Coral was a provision of blood handling services to hospitals. | ||||
 Cytomed | US | Early Stage | Biotechnology Biopharmaceuticals | 1997 |
| Cytomed was a leukotriene inhibitors for asthma (Acquired by LeukoSite Inc and then by Millenium). | ||||
 Euro Dentalversand | Germany | Buyout | Healthcare Services | 2000 |
| Euro was mail order dental consumables. | ||||
 Geltex Pharmaceuticals | US | Early Stage | Biotechnology Biopharmaceuticals | 1998 |
| Geltex developed novel non-absorbed pharmaceuticals. Geltex was acquired by Genzyme Corporation after our exit through public markets. | ||||
 General Surgical Innovations | US | Early Stage | Medical Devices Instrumentation | 1995 |
| General Surgical Innovations is a minimally invasive approach to hernia repair and incontinence (purchased by United States Surgical). | ||||
 Genosis | UK | Start Up | Medical Devices Instrumentation | 1999 |
| Genosis has developed home use diagnostic devices to assess fertility in couples of childbearing age. Genosis products - Fertell, which provide both male and female tests, are available over the counter in the UK and the US and provide couples with the tools required to assess their fertility in the privacy of their homes. | ||||
 Heritage Health Systems | US | Early Stage | Healthcare Services | 1995 |
| Heritage was a physician practice. | ||||
 Incyte Pharmaceuticals | UK | Start Up | Biotechnology Biopharmaceuticals | 1996 |
| Functional genomics Acquired by Incyte Pharmaceuticals in September 1999. | ||||
 JC Nationwide | US | Buyout | Healthcare Services | 1995 |
| JC Nationwide was a physician recruitment agency. | ||||
 Kinetix Pharmaceuticals | US | Start Up | Biotechnology Biopharmaceuticals | 1999 |
| Kinase targeted drug discovery. Acquired by Amgen in October 2000. | ||||
 Leica Microsystems | Germany | Buyout | Medical Devices Instrumentation | 1998 |
| Leica Manufactured and marketed microscopes and neurosurgical equipment. | ||||
 LeukoSite | US | Start Up | Biotechnology Biopharmaceuticals | 1994 |
| LeukoSite was a treatment of Inflammatory diseases and cancer. Acquired by Amgen in October 1999. | ||||
 MedNova | Ireland | Start Up | Medical Devices Instrumentation | 1996 |
| MedNova was a device for interventional radiology and cardiology. | ||||
 Metris Therapeutics | UK | Start Up | Biotechnology Biopharmaceuticals | 2000 |
| Metris is a women's healthcare company that is developing drugs for the treatment of chronic gynecological and menstrual conditions. | ||||
 Micromass | UK | Buyout | Medical Devices Instrumentation | 1996 |
| Micromass was a minimally invasive approach to hernia repair and incontinence (purchased by Waters). | ||||
 MicroMed | US | Early Stage | Medical Devices Instrumentation | 1998 |
| MicroMed based in Houston, TX, has developed an implantable pump for use as a Left Ventricular Assist Device (LVAD) to aid the heart's pumping action in patients suffering from congestive heart failure. | ||||
 Micromet | US | Start Up | Biotechnology Biopharmaceuticals | 1998 |
| (NASDAQ: MITI) Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibody-based therapies for the treatment of cancer. | ||||
 Nexan | UK | Start Up | Medical Devices Instrumentation | 1996 |
| Nexan was a remote telemonitoring devices. | ||||
 OMS Foundations | US | Early Stage | Healthcare Services | 1998 |
| OMS Foundations was an oral maxillofacial physician practice management. | ||||
 Orthovita | US | Early Stage | Medical Devices Instrumentation | 1997 |
| Orthovita was a novel bone substitute materials company. | ||||
 Pelton & Crane | US | Buyout | Healthcare Services | 1997 |
| Pelton & Crane developed sterilization equipment. | ||||
 Shire Pharmaceuticals | US | Early Stage | Biotechnology Biopharmaceuticals | 1994 |
| Ticker: SHP LN Shire Pharmaceuticals - speciality pharma company formed on osteoporosis and Alzheimer's disease. | ||||
 Sirona Dental Systems | Germany | Buyout | Medical Devices Instrumentation | 1997 |
| Sirona was a dental equipment manufacturer. | ||||
 Strides Arcolab | India | Expansion | Biotechnology Biopharmaceuticals | 1997 |
| Strides Arcolab was a manufacturer of generic pharmaceuticals. | ||||
 TLC Vision | US | Expansion | Healthcare Services | 1995 |
| TLC Vision was a service provider for laser-based ophthalmic surgery. Formerly known as Laservision. | ||||
 Triangle Pharmaceuticals | US | Start Up | Biotechnology Biopharmaceuticals | 1995 |
| Triangle Pharmaceuticals was an antiviral and anticancer drug development company. Acquired by Gilead in January 2003. | ||||
 Vanguard Medica (Vernalis) | UK | Early Stage | Biotechnology Biopharmaceuticals | 1995 |
| Vanguard Medica was an antiviral and anticancer drug development company. (Acquired by Vernalis) | ||||
 Vintage BioMed | US | Seed | Healthcare Services | 1996 |
| Vintage BioMed was a capital equipment leasing and maintenance company. | ||||